SIRT7
Basic information
Region (hg38): 17:81911939-81921323
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SIRT7 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 28 | 29 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 28 | 1 | 0 |
Variants in SIRT7
This is a list of pathogenic ClinVar variants found in the SIRT7 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-81912441-C-G | not specified | Uncertain significance (Mar 16, 2024) | ||
17-81912451-A-G | not specified | Uncertain significance (Jun 30, 2024) | ||
17-81912495-G-A | not specified | Uncertain significance (Oct 27, 2022) | ||
17-81912504-C-T | not specified | Likely benign (Aug 16, 2021) | ||
17-81912517-G-C | not specified | Uncertain significance (May 23, 2024) | ||
17-81912579-A-G | not specified | Uncertain significance (Jan 01, 2025) | ||
17-81912583-G-A | not specified | Uncertain significance (Apr 22, 2024) | ||
17-81912594-G-A | not specified | Uncertain significance (Jan 03, 2024) | ||
17-81912611-C-G | not specified | Uncertain significance (Jan 24, 2025) | ||
17-81913783-G-A | not specified | Uncertain significance (Mar 10, 2025) | ||
17-81914101-T-C | not specified | Uncertain significance (Jan 07, 2025) | ||
17-81914124-G-C | not specified | Uncertain significance (Aug 03, 2021) | ||
17-81914163-A-G | not specified | Uncertain significance (Jun 03, 2024) | ||
17-81914311-G-C | not specified | Uncertain significance (Oct 09, 2024) | ||
17-81914349-G-A | not specified | Uncertain significance (Oct 07, 2024) | ||
17-81914352-G-A | not specified | Uncertain significance (May 16, 2023) | ||
17-81914393-A-C | not specified | Uncertain significance (Aug 03, 2022) | ||
17-81914443-G-A | not specified | Uncertain significance (Jan 19, 2025) | ||
17-81914472-C-T | not specified | Uncertain significance (Sep 26, 2023) | ||
17-81914621-C-T | not specified | Uncertain significance (Oct 02, 2023) | ||
17-81914623-T-C | not specified | Uncertain significance (Sep 02, 2024) | ||
17-81914644-C-T | not specified | Uncertain significance (Dec 28, 2024) | ||
17-81914645-G-A | not specified | Uncertain significance (May 17, 2023) | ||
17-81915453-T-C | not specified | Uncertain significance (Dec 23, 2024) | ||
17-81915471-A-G | not specified | Uncertain significance (Jun 28, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SIRT7 | protein_coding | protein_coding | ENST00000328666 | 10 | 9385 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000556 | 0.976 | 125641 | 0 | 7 | 125648 | 0.0000279 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.885 | 202 | 241 | 0.839 | 0.0000156 | 2535 |
Missense in Polyphen | 49 | 83.233 | 0.58871 | 892 | ||
Synonymous | -2.13 | 135 | 107 | 1.26 | 0.00000737 | 836 |
Loss of Function | 2.00 | 8 | 16.9 | 0.475 | 7.19e-7 | 208 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000114 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000451 | 0.0000440 |
Middle Eastern | 0.000114 | 0.000109 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: NAD-dependent protein deacetylase that specifically mediates deacetylation of histone H3 at 'Lys-18' (H3K18Ac). In contrast to other histone deacetylases, displays selectivity for a single histone mark, H3K18Ac, directly linked to control of gene expression. H3K18Ac is mainly present around the transcription start site of genes and has been linked to activation of nuclear hormone receptors. SIRT7 thereby acts as a transcription repressor. Moreover, H3K18 hypoacetylation has been reported as a marker of malignancy in various cancers and seems to maintain the transformed phenotype of cancer cells. These data suggest that SIRT7 may play a key role in oncogenic transformation by suppresses expression of tumor suppressor genes by locus-specific deacetylation of H3K18Ac at promoter regions. Also required to restore the transcription of ribosomal RNA (rRNA) at the exit from mitosis: promotes the association of RNA polymerase I with the rDNA promoter region and coding region. Stimulates transcription activity of the RNA polymerase I complex. May also deacetylate p53/TP53 and promotes cell survival, however such data need additional confirmation. {ECO:0000269|PubMed:16618798, ECO:0000269|PubMed:19174463, ECO:0000269|PubMed:22722849}.;
- Pathway
- NAD+ metabolism;NAD+ biosynthetic pathways;Signaling events mediated by HDAC Class III
(Consensus)
Recessive Scores
- pRec
- 0.141
Intolerance Scores
- loftool
- 0.538
- rvis_EVS
- -0.12
- rvis_percentile_EVS
- 45.13
Haploinsufficiency Scores
- pHI
- 0.173
- hipred
- Y
- hipred_score
- 0.704
- ghis
- 0.504
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.873
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sirt7
- Phenotype
- liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); pigmentation phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); skeleton phenotype; cellular phenotype; immune system phenotype; homeostasis/metabolism phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; muscle phenotype;
Zebrafish Information Network
- Gene name
- sirt7
- Affected structure
- hematopoietic progenitor cell differentiation
- Phenotype tag
- abnormal
- Phenotype quality
- decreased occurrence
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;positive regulation of transcription involved in exit from mitosis;rRNA transcription;histone H3 deacetylation;histone H4 deacetylation
- Cellular component
- nucleolus;nucleolus organizer region;cytoplasm
- Molecular function
- chromatin binding;protein binding;metal ion binding;NAD+ binding;NAD-dependent histone deacetylase activity (H3-K18 specific)